Skip to main content

Tzianabos Arthur's Form 4 filing

Q32 Bio Inc. (QTTB) · filed Feb 15, 2024

Accession no.
0000950170-24-015944
Filed
Feb 15, 2024
Trade date
Jan 1-9, 2024
Filing delay
45 daysLate
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.43K. It was filed 45 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tzianabos ArthurCIK 0001586226Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 1, 2024Common StockMOption exerciseAcquired+14,280––122,675Direct
Jan 1, 2024Common StockMOption exerciseAcquired+19,140––141,815Direct
Jan 9, 2024Common StockSSaleDisposed−13,037$0.57−$7,431.09128,778Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 1, 2024Common StockMOption exerciseDisposed−14,280$0.00$00Direct
Jan 1, 2024Common StockMOption exerciseDisposed−19,140$0.00$019,720Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)